PROCEPT BioRobotics Corporation

NasdaqGM PRCT

PROCEPT BioRobotics Corporation Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2024: USD 12.46 M

PROCEPT BioRobotics Corporation Net Cash Used Provided By Financing Activities is USD 12.46 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -92.38% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • PROCEPT BioRobotics Corporation Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 163.61 M, a 2,835.25% change year over year.
  • PROCEPT BioRobotics Corporation Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 5.57 M, a -97.87% change year over year.
  • PROCEPT BioRobotics Corporation Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 261.71 M.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
NasdaqGM: PRCT

PROCEPT BioRobotics Corporation

CEO Dr. Reza Zadno Ph.D.
IPO Date Sept. 15, 2021
Location United States
Headquarters 900 Island Drive
Employees 626
Sector Technology
Industries
Description

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Similar companies

FNA

Paragon 28, Inc.

USD 10.28

-4.28%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

SIBN

SI-BONE, Inc.

USD 15.70

-3.27%

ESTA

Establishment Labs Holdings Inc.

USD 33.15

-1.66%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

RXST

RxSight, Inc.

USD 30.08

-2.08%

TMCI

Treace Medical Concepts, Inc.

USD 8.01

-4.19%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email